Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (401-410 of 430) with videos related to

Pageof 43
Sort By:
Thorax|May 27, 2025
<sup>129</sup>Xe-MRI ventilation and acinar abnormalities highlight the significance of spirometric dysanapsis: findings from the NOVELTY ADPro UK substudyLaurie J Smith, Helen Marshall, Demi Jakymelen, et al.
The European Respiratory Journal|June 15, 2019
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesisMalcolm R Starkey, Maximilian W Plank, Paolo Casolari, et al.
The Journal of Allergy and Clinical Immunology|January 4, 2026
Nasal gene expression shows a distinct signature in T2-high asthma but not in T2-low diseaseTatiana Karp, Simon Kebede Merid, Nazanin Zounemat Kermani, et al.
Lancet (London, England)|May 18, 2026
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trialsAlberto Papi, Neil J Greening, Surya P Bhatt, et al.
The Lancet. Respiratory Medicine|July 30, 2022
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS studyTessa M Kole, Elise Vanden Berghe, Monica Kraft, et al.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
Molecular & Cellular Proteomics : MCP|December 8, 2023
Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 PatientsAlbert Bondt, Max Hoek, Kelly Dingess, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2025
Phenotyping Asthma and/or COPD Using <sup>129</sup>Xe MRI and Comprehensive Physiologic TestingHelen Marshall, Laurie J Smith, Alberto M Biancardi, et al.
American Journal of Respiratory Cell and Molecular Biology|January 21, 2025
Improved Annotation of Asthma Gene Variants with Cell Type Deconvolution of Nasal and Lung Expression Quantitative Trait LociZaid W El-Husseini, Tatiana Karp, Andy Lan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 31, 2015
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPDAnta Ngkelo, Roland F Hoffmann, Andrew L Durham, et al.
Pageof 43

Showing results (401-410 of 430) with videos related to

Sort By:
Pageof 43
Thorax|May 27, 2025
<sup>129</sup>Xe-MRI ventilation and acinar abnormalities highlight the significance of spirometric dysanapsis: findings from the NOVELTY ADPro UK substudyLaurie J Smith, Helen Marshall, Demi Jakymelen, et al.
The European Respiratory Journal|June 15, 2019
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesisMalcolm R Starkey, Maximilian W Plank, Paolo Casolari, et al.
The Journal of Allergy and Clinical Immunology|January 4, 2026
Nasal gene expression shows a distinct signature in T2-high asthma but not in T2-low diseaseTatiana Karp, Simon Kebede Merid, Nazanin Zounemat Kermani, et al.
Lancet (London, England)|May 18, 2026
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trialsAlberto Papi, Neil J Greening, Surya P Bhatt, et al.
The Lancet. Respiratory Medicine|July 30, 2022
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS studyTessa M Kole, Elise Vanden Berghe, Monica Kraft, et al.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
Molecular & Cellular Proteomics : MCP|December 8, 2023
Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 PatientsAlbert Bondt, Max Hoek, Kelly Dingess, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2025
Phenotyping Asthma and/or COPD Using <sup>129</sup>Xe MRI and Comprehensive Physiologic TestingHelen Marshall, Laurie J Smith, Alberto M Biancardi, et al.
American Journal of Respiratory Cell and Molecular Biology|January 21, 2025
Improved Annotation of Asthma Gene Variants with Cell Type Deconvolution of Nasal and Lung Expression Quantitative Trait LociZaid W El-Husseini, Tatiana Karp, Andy Lan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 31, 2015
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPDAnta Ngkelo, Roland F Hoffmann, Andrew L Durham, et al.
Pageof 43